Glaxo and Genmab drop IV version of MS immune drug
Glaxo and Genmab drop IV version of MS immune drug
GlaxoSmithKline PLC and Genmab A/S will end the development of an intravenous form of a drug intended to treat autoimmune diseases like lupus and multiple sclerosis, and focus on an injectable version.
The companies said an injectable version of Arzerra (ofatumumab) should be more convenient for patients and have fewer side effects. The drug can also be used to treat rheumatoid arthritis...Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1397
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 1 Replies
- 1633 Views
-
Last post by goellerc
-
- 0 Replies
- 1108 Views
-
Last post by ElliotB
-
- 61 Replies
- 13233 Views
-
Last post by jimmylegs
-
- 3 Replies
- 4860 Views
-
Last post by NHE
-
- 5 Replies
- 12892 Views
-
Last post by gibbledygook
-
- 1 Replies
- 1485 Views
-
Last post by ElliotB
-
- 0 Replies
- 669 Views
-
Last post by DIM
-
- 0 Replies
- 437 Views
-
Last post by NHE
-
- 0 Replies
- 1385 Views
-
Last post by NHE